We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+7.16%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$7.42B
AUM Growth
+$1.24B
(+20%)
Cap. Flow
+$985M
Cap. Flow
% of AUM
13.27%
Top 10 Holdings %
Top 10 Hldgs %
10.68%
Holding
3,037
New
854
Increased
791
Reduced
777
Closed
600
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$49.3M |
| 2 |
Intuit
INTU
|
+$48.7M |
| 3 |
Costco
COST
|
+$47.9M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$47.4M |
| 5 |
Vanguard Real Estate ETF
VNQ
|
+$45.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$41M |
| 2 |
Dollar General
DG
|
+$39M |
| 3 |
Biogen
BIIB
|
+$36.8M |
| 4 |
iShares US Real Estate ETF
IYR
|
+$29.8M |
| 5 |
Waste Management
WM
|
+$29.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.19% |
| 2 | Consumer Discretionary | 16.12% |
| 3 | Healthcare | 11.21% |
| 4 | Financials | 10.17% |
| 5 | Industrials | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
IMAX
IMAX
$2.38B
| $332K | ﹤0.01% |
27,734
-32,291
| -54% | -$417K |
|
1727
Inovio Pharmaceuticals
INO
$79.8M
| $332K | ﹤0.01% |
2,383
-292
| -11% | -$60.9K |
|
1728
OrthoPediatrics
KIDS
$485M
| $332K | ﹤0.01% |
7,235
-6,342
| -47% | -$294K |
|
1729
OFG Bancorp
OFG
$2.21B
| $332K | ﹤0.01% |
26,664
+5,807
| +28% | +$76.1K |
|
|
ALE
1730
DELISTED
Allete
ALE
| $331K | ﹤0.01% |
6,390
+869
| +16% | +$48.4K |
|
1731
Banco Bradesco
BBD
$38.1B
| $330K | ﹤0.01% |
+116,283
| New | +$381K |
|
1732
Archrock
AROC
$6.33B
| $329K | ﹤0.01% |
+61,139
| New | +$400K |
|
1733
CALL
Caterpillar
CAT
$409B
| $328K | ﹤0.01% |
+2,200
| New | +$309K |
|
|
1734
PUT
Caterpillar
CAT
$409B
| $328K | ﹤0.01% |
+2,200
| New | +$309K |
|
1735
Gildan
GIL
$9.25B
| $328K | ﹤0.01% |
+16,679
| New | +$308K |
|
1736
Vipshop
VIPS
$6.84B
| $327K | ﹤0.01% |
20,885
-6,875
| -25% | -$135K |
|
|
LTRPA
1737
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $325K | ﹤0.01% |
188,007
+104,514
| +125% | +$252K |
|
1738
Heron Therapeutics
HRTX
$86.3M
| $324K | ﹤0.01% |
+21,846
| New | +$341K |
|
|
LITS
1739
Lite Strategy Inc
LITS
$33.6M
| $324K | ﹤0.01% |
5,185
+3,084
| +147% | +$186K |
|
1740
Materion
MTRN
$5.01B
| $324K | ﹤0.01% |
6,219
-9,346
| -60% | -$529K |
|
|
OPRA
1741
Opera Ltd
OPRA
$1.65B
| $324K | ﹤0.01% |
+33,116
| New | +$311K |
|
1742
Lightpath Technologies
LPTH
$680M
| $323K | ﹤0.01% |
+134,202
| New | +$390K |
|
|
ELVT
1743
DELISTED
Elevate Credit, Inc.
ELVT
| $323K | ﹤0.01% |
125,740
+69,718
| +124% | +$148K |
|
1744
Flotek Industries
FTK
$935M
| $321K | ﹤0.01% |
19,743
-1,549
| -7% | -$18.1K |
|
1745
Par Pacific Holdings
PARR
$3.88B
| $321K | ﹤0.01% |
47,442
-9,952
| -17% | -$82.4K |
|
|
ECOM
1746
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $321K | ﹤0.01% |
+22,213
| New | +$369K |
|
|
1747
CALL
Costco
COST
$415B
| $320K | ﹤0.01% |
+900
| New | +$302K |
|
|
1748
PUT
Costco
COST
$415B
| $320K | ﹤0.01% |
+900
| New | +$302K |
|
1749
Culp Inc
CULP
$45M
| $320K | ﹤0.01% |
25,737
-11,909
| -32% | -$134K |
|
1750
Essential Utilities
WTRG
$11.2B
| $320K | ﹤0.01% |
7,951
-5,428
| -41% | -$233K |
|
Similar funds
Squarepoint's Q3 2020 Portfolio in Review
As of Q3 2020, Squarepoint held 3,037 positions worth $7.42B, up 20% from $6.18B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Squarepoint deployed $985M of net new capital in Q3 2020, opening 854 new positions and adding to 791 existing holdings. Its largest new stake was Salesforce: 186,017 shares worth $46.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Pfizer, an estimated $41M trimmed.
- Squarepoint's largest Q3 2020 buy was Salesforce: 186,017 shares worth $46.8M.
- Squarepoint added most to Visa in Q3 2020, an estimated $49.3M increase.
- Squarepoint's biggest Q3 2020 reduction was Pfizer, cutting an estimated $41M.
- Squarepoint fully exited Biogen in Q3 2020, selling an estimated $36.8M.
- Squarepoint's ten largest holdings make up 11% of its $7.42B portfolio in Q3 2020.
- Squarepoint opened 854 new positions and closed 600 in Q3 2020.
- Squarepoint's portfolio value rose 20% quarter-over-quarter to $7.42B.
Based on Squarepoint's 13F filing for Q3 2020, filed 16 Nov 2020.